US hospitals slash use of hydroxychloroquine, drug championed by Trump as COVID-19 treatment

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

U.S. hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald Trump as a COVID-19 ...

Dr Thomas McGinn, deputy physician in chief at Northwell Health, New York's largest healthcare system, told Reuters it decided to stop prescribing hydroxychloroquine at its 23 hospitals in mid-April, after clinical data began to emerge.

British medical journal The Lancet last week published an analysis of 96,000 COVID-19 patients showing those treated with hydroxychloroquine or the related chloroquine had higher risk of death and heart rhythm problems. Seattle's University of Washington hospital system has also stopped recommending hydroxychloroquine as a coronavirus standard of care, noting in its latest treatment guidelines that"recent clinical studies have not demonstrated virologic or clinical benefits."

Results could be released as early as this week for two of the University of Minnesota's three hydroxychloroquine trials, according to Dr Radha Rajasingham, lead researcher for one of the studies.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Any plans to tweet about the flawed study?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines